Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study

Huang, CS; Yang, YS; Kwong, A; Chen, SC; Tseng, LM; Liu, MC; Shen, KW; Wang, SS; Ng, TY; Feng, Y; Sun, GF; Yan, IR; Shao, ZM

Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China.

BREAST CANCER RESEARCH AND TREATMENT, 2021; 187 (3): 759

Abstract

Purpose In the KATHERINE study (NCT01772472), patients with HER2-positive early breast cancer (EBC) and residual invasive disease after neoadjuvant ch......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索